Health Care & Life Sciences

Analysts grill Lilly execs on strategy after setbacks

October 21, 2010
J.K. Wall
Wall Street analysts on Thursday demanded to know what new things Eli Lilly and Co. is planning since the company’s vaunted pipeline has failed to produce a drug that will boost revenue after a wave of patent expirations. The answer: Not much.
More

Home Health Depot acquires Arcadia subsidiary

October 21, 2010
The division purchased by Home Health Depot markets and sells home health related items via mail and online. Terms of the deal were not disclosed.
More

Lilly raises forecast after beating third-quarter profit estimates

October 21, 2010
J.K. Wall
The Indianapolis-based drugmaker reported a profit of $1.3 billion in the quarter ended Sept. 30, up 38 percent compared with last year. Excluding extraordinary items from a year ago, Lilly’s profit was up 2 percent.
More

Lilly suspends clinical trials after diabetes treatment fails

October 20, 2010
Bloomberg News
Eli Lilly and Co. and its development partner said an experimental diabetes treatment failed to help patients in a late-stage study, the second setback for a Lilly diabetes drug candidate in two days.
More

Some Lilly-paid docs sport spotty records

October 20, 2010
J.K. Wall
Eli Lilly and Co. paid more than $102 million last year and early this year to physicians for talking up Lilly drugs to other doctors. Yet 88 of the doctors Lilly pays have been sanctioned by state medical boards.
More

'Payer mix' playing role in hospital merger

October 20, 2010
J.K. Wall
Morgan Hospital & Medical Center is on the brink of merging with Clarian Health for a variety of reasons, but one of the biggest is one that all hospitals are facing in one way or another: a declining payer mix.
More

Q&A

October 20, 2010
J.K. Wall

Amy Zucker is president of Indianapolis-based Synergy Marketing Group. Her firm was recently hired by Indianapolis-based ImmuneWorks Inc. to use a new website and search engine optimization to help recruit patients for a Phase 1 trial of ImmuneWorks experimental medicine idiopathic pulmonary fibrosis. The Web strategy is a new wrinkle on patient recruitment—in addition to the traditional partnerships with disease specialists at academic medical centers—that Zucker hopes leads to lower costs and faster clinical trials. Phase 1 clinical trials cost nearly $16,000 per patient.

More

Principal Financial shift to result in local layoffs

October 20, 2010
 IBJ Staff
Financial giant Principal Financial Group Inc. is exiting the health insurance business, a move that will cost 60 Indianapolis workers their jobs.
More

Lilly to close drug discovery center in Singapore

October 18, 2010
Bloomberg News
Indianapolis-based Eli Lilly and Co. will close its drug discovery center in Singapore, three years into a five-year, $150 million plan to expand it.
More

Prosolia Inc. restructures top management

October 16, 2010
 IBJ Staff
The company, which develops mass spectrometry devices used in the life sciences and industrial chemistry, has a new CEO, among other changes.
More

City pitching in $38M for $192M Clarian project

October 14, 2010
Cory Schouten
The city is kicking in up to $38 million for infrastructure upgrades to support a massive expansion of the Clarian Health campus at 16th Street and Capitol Avenue.
More

WellPoint, Aetna led U.S. insurers in coverage denial

October 13, 2010
Bloomberg News
Until all consumers are required to buy health insurance, coverage restrictions are needed to keep people from gaming the system, insurers say.
More

Lilly falls short on 'field goal' attempt

October 13, 2010
J.K. Wall
Eli Lilly and Co.’s “miss” on a new use for its cancer drug Alimta was a rare failure to get an existing drug approved for a new use—even though the company has struggled mightily to get entirely new drugs to market.
More

IU shrink explores mental health blood tests

October 13, 2010
J.K. Wall
Dr. Alexander B. Niculescu, a psychiatrist at the IU School of Medicine, has won a five-year, $1.5 million grant from the National Institutes of Health to hunt for the presence of certain proteins in the blood that would indicate that a patient suffers from a mood disorder, which afflicts one in five Americans.
More

Developer of Binford Medical Complex files for Chapter 11

October 12, 2010
Cory Schouten
The developer of an unfinished medical office complex on Binford Boulevard has filed for Chapter 11 bankruptcy protection in hopes it can retain control of the property and resume construction later this year.
More

WellPoint, other insurers' stock buybacks concern investors

October 12, 2010
Bloomberg News
Indianapolis-based WellPoint Inc. and competing U.S. health insurers approved $10 billion in stock repurchases in the past year, a concern to investors who say buybacks failed to increase share prices and who want more spent on dividends.
More

OneAmerica dodged crisis, now reaps rewardsRestricted Content

October 9, 2010
Greg Andrews
The Indianapolis-based life insurer's investment portfolio held up through the recession, and the company reported record revenue and profit in 2009.
More

Beckman Coulter plans $18.2M expansion, 100 new jobs

October 8, 2010
 IBJ Staff
California-based life sciences firm Beckman Coulter Inc. is planning its third local expansion since 2007, investing $18.2 million in its Indianapolis operation and adding as many as 95 jobs here in the next three years.
More

Consultants: Pharma industry facing huge changes

October 6, 2010
J.K. Wall
Heitzman_WatchVideoTo date, most analysts say health reform turned out pretty well for the pharmaceutical industry. But a detailed analysis by Deloitte Consulting says the indirect effects of reform will deliver a gut punch to the industry that will lead to full-scale transformation akin to what the telecommunications world has seen over the past three decades.
More

Insurers cautious on accountable care

October 6, 2010
J.K. Wall
Health insurers, including locally based WellPoint Inc. and Advantage Health Solutions, have been looking to work with health care providers to form accountable-care organizations. But they also worry that the accountable-care concept will become nothing more than a negotiating tactic by hospitals and doctors.
More

Q&A

October 6, 2010
J.K. Wall
Dale Hockel is vice president of clinical engineering services at TriMedX, which helps hospitals and health care facilities keep their medical equipment running even as it ages. TriMedX grew its number of clients in 2009 by 36 percent to a total of 739 health care facilities.
More

Health reform forces providers, insurers to lay aside rivalriesRestricted Content

October 2, 2010
Scott Olson
In this new age of health care, ushered in by President Obama’s signing in March of a sweeping health care reform law, health care players are encouraged to remove the gloves if they want to reap the benefits of reform.
More

My Health Care Manager wins $1.25M to improve software

October 2, 2010
 IBJ Staff
The Indianapolis-based firm that helps seniors and their care givers navigate the health care system won a nearly $1.2 million grant from the National Institutes of Health.
More

Drugmakers’ ‘doughnut hole’ deal to shave sales

October 1, 2010
Bloomberg News
Drugmakers including Pfizer Inc., AstraZeneca, Bristol-Myers Squibb Co. and Eli Lilly and Co. may provide more than $2 billion in drug discounts to senior citizens next year under a deal pharmaceutical companies made with the White House.
More

Lilly sues drug distributor over generic Zyprexa sales

September 29, 2010
Bloomberg News
Celesio's Lloyds Pharmacy and Aah Pharmaceuticals businesses sold about 800,000 tablets of generic Zyprexa before agreeing in 2008 to halt sales, Lilly said in a complaint filed in the High Court in London.
More
Page  << 61 62 63 64 65 66 67 68 69 70 >> pager
Sponsored by
ADVERTISEMENT

facebook - twitter on Facebook & Twitter

Follow on TwitterFollow IBJ on Facebook:
Follow on TwitterFollow IBJ's Tweets on these topics:
 
Subscribe to IBJ
ADVERTISEMENT